XENT
Intersect ENT, Inc
XENT
XENT
Delisted
XENT was delisted on the 12th of May, 2022.
115 hedge funds and large institutions have $528M invested in Intersect ENT, Inc in 2015 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 44 increasing their positions, 39 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
8% less funds holding
Funds holding: 125 → 115 (-10)
37% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 27
Holders
115
Holding in Top 10
2
Calls
$1.13M
Puts
$1.13M
Top Buyers
1 | +$42.8M | |
2 | +$14.3M | |
3 | +$13.7M | |
4 |
RIM
RS Investment Management
San Francisco,
California
|
+$12.1M |
5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$6.84M |
Top Sellers
1 | -$25.3M | |
2 | -$12.7M | |
3 | -$10.4M | |
4 |
FAM
Fred Alger Management
New York
|
-$8.23M |
5 |
PC
Pier Capital
Stamford,
Connecticut
|
-$6.72M |